Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kappos

Showing results (61-70 of 225) with videos related to

Pageof 23
Sort By:
Journal of the Neurological Sciences|June 9, 2009
Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosisK Bendfeldt, L Kappos, E W Radue, et al.
European Neurology|January 1, 1990
Occurrence of MRI abnormalities in patients with isolated optic neuritisD Städt, L Kappos, E Rohrbach, et al.
Psychiatry Research|September 1, 1989
Correlation of MRI findings and neuropsychological results in patients with multiple sclerosisU Mann, D Staedt, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 1999
Use of composite scores in the quantification of deterioration in multiple sclerosisC Lienert, J Lechner-Scott, D Schött, et al.
Journal of Neurology|February 1, 2000
Combined acute disseminated encephalomyelitis and acute motor axonal neuropathy after vaccination for hepatitis A and infection with Campylobacter jejuniS Huber, L Kappos, P Fuhr, et al.
Neurology|February 23, 2011
Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosisM Mehling, T A Johnson, J Antel, et al.
Journal of Neuroimmunology|December 1, 1988
Myelin-specific T lymphocytes in multiple sclerosis patients and healthy individualsB Kitze, M Pette, E Rohrbach, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 22, 2014
Prediction of MS disability by multimodal evoked potentials: investigation during relapse or in the relapse-free interval?R Schlaeger, M D'Souza, C Schindler, et al.
Neurology|December 12, 2001
Final analysis of the European multicenter trial on IFNbeta-1b in secondary-progressive MSL Kappos, C Polman, C Pozzilli, et al.
Lancet (London, England)|November 19, 1988
Magnetic resonance imaging and early diagnosis of multiple sclerosisR Heun, L Kappos, S Bittkau, et al.
Pageof 23

Showing results (61-70 of 225) with videos related to

Sort By:
Pageof 23
Journal of the Neurological Sciences|June 9, 2009
Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosisK Bendfeldt, L Kappos, E W Radue, et al.
European Neurology|January 1, 1990
Occurrence of MRI abnormalities in patients with isolated optic neuritisD Städt, L Kappos, E Rohrbach, et al.
Psychiatry Research|September 1, 1989
Correlation of MRI findings and neuropsychological results in patients with multiple sclerosisU Mann, D Staedt, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 1999
Use of composite scores in the quantification of deterioration in multiple sclerosisC Lienert, J Lechner-Scott, D Schött, et al.
Journal of Neurology|February 1, 2000
Combined acute disseminated encephalomyelitis and acute motor axonal neuropathy after vaccination for hepatitis A and infection with Campylobacter jejuniS Huber, L Kappos, P Fuhr, et al.
Neurology|February 23, 2011
Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosisM Mehling, T A Johnson, J Antel, et al.
Journal of Neuroimmunology|December 1, 1988
Myelin-specific T lymphocytes in multiple sclerosis patients and healthy individualsB Kitze, M Pette, E Rohrbach, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 22, 2014
Prediction of MS disability by multimodal evoked potentials: investigation during relapse or in the relapse-free interval?R Schlaeger, M D'Souza, C Schindler, et al.
Neurology|December 12, 2001
Final analysis of the European multicenter trial on IFNbeta-1b in secondary-progressive MSL Kappos, C Polman, C Pozzilli, et al.
Lancet (London, England)|November 19, 1988
Magnetic resonance imaging and early diagnosis of multiple sclerosisR Heun, L Kappos, S Bittkau, et al.
Pageof 23